BSX
Boston ScientificDNYSE / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Procedure volumes recover quickly, new product launches gain commercial traction, and reimbursement remains stable—driving margin expansion and a rerating toward the bull target (155) within 12 months.
Posture
Defensive
Lead driver
Sentiment
What changed
2 setup hits (3d) with net bearish as of 2026-06-02.
What can break
Large legal judgments or elevated litigation reserve
Momentum
5
Value
60
Sentiment
75
Setup hits (3d)
2 · Net Bearish
AI TargetsBase $115.00 · Bull $155.00 · Bear $85.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2025-10-23 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bearish
Target $104.00
Why
Momentum5 · Δ7d -2.6
Value60 · Δ7d +2.3
Sentiment75 · Δ7d 0.0
So what
Weak posture (Net Bearish). Prioritize risk control and patience.
Lead driver: Sentiment · See AI snapshot
Momentum
5
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.6
Δ21d
+0.5
Value
60
32% active weight
Current posture
7d trendImproving
Δ7d
+2.3
Δ21d
+1.8
Sentiment
75
33% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade D. Momentum 5.4 / Value 60.1 / Sentiment 74.7
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$71.32B
Beta
0.67
Shares Out
1.48B
P/E (TTM)
51.1
P/S (TTM)
7.31
P/FCF (TTM)
37.02
Rev YoY
+20.3%
EPS YoY
+60.1%
Gross Margin
+68.6%
Op Margin
+17.9%
Net Debt
$10.33B
Current Ratio
1.51
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology